Cannabidiol for Fibromyalgia (The CANNFIB Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

February 14, 2024

Study Completion Date

February 14, 2024

Conditions
Fibromyalgia
Interventions
DRUG

Cannabidiol

Participants will start with 10 mg of cannabidiol daily and the dose will be escalated every third day until the maximum dosage of 50 mg is reached (after two weeks). The participants be on the 50 mg dosage of cannabidiol for 24 weeks.

DRUG

Placebo

Placebo is administered as tablets of 10 mg that are identical in appearance, taste, and smell to the Cannabidiol tablets.The participants will be on the 50 mg dosage of placebo for 24 weeks.

Trial Locations (1)

2000

The Parker Institute, Frederiksberg Hospital, Copenhagen

All Listed Sponsors
lead

Marius Henriksen

OTHER

NCT04729179 - Cannabidiol for Fibromyalgia (The CANNFIB Trial) | Biotech Hunter | Biotech Hunter